Summary: SUMO proteins are essential for reactivating dormant neural stem cells, a process critical for brain repair and regeneration. This discovery — centered on SUMOylation — explains how neural stem cells can be “woken up” to support recovery after injury and suggests new avenues for therapies against neurodegenerative diseases.
Researchers show that SUMOylation controls neural stem cell reactivation by modulating the Hippo signaling pathway, a central regulator of cell growth and tissue homeostasis. These findings provide a molecular foundation for regenerative approaches targeting conditions such as Alzheimer’s and Parkinson’s disease.
Key facts
- SUMO proteins promote the exit of neural stem cells from dormancy, enabling brain repair.
- SUMOylation inhibits the Hippo pathway’s growth-suppressing activity to allow stem cell proliferation.
- Results point to potential regenerative therapies for neurodegenerative disorders and developmental brain conditions.
Source: Duke NUS Medical School
Overview
An international team led by Duke-NUS Medical School has identified a conserved biochemical mechanism that governs the reactivation of neural stem cells. Published in Nature Communications, the study clarifies how SUMO proteins and the SUMOylation process influence brain development and the ability of neural stem cells to respond to demand — for example, after injury or with increased activity.
Neural stem cells generate most of the brain’s nerve cells. After early development these stem cells typically enter a dormant or quiescent state to preserve resources. They only reactivate when the brain needs regeneration — for example, following damage or during certain forms of stimulation. With age, the pool of reactivatable neural stem cells shrinks, contributing to reduced regenerative capacity and a higher risk of neurological disorders.
This study reveals that SUMOylation — the attachment of small ubiquitin-like modifier (SUMO) proteins to target proteins — is a key switch for reactivation. SUMO-tagged proteins change how target proteins behave, enabling molecular programs that drive stem cells back into proliferation. In fruit fly models, removing SUMO proteins caused severe defects in neural stem cell activation and produced underdeveloped brains resembling microcephaly, demonstrating a direct developmental consequence of disrupted SUMOylation.
Dr Gao Yang, the study’s first author and a research fellow at the Duke-NUS Neuroscience and Behavioural Disorders Programme, explained that this work is the first to identify the SUMO family as essential regulators of neural stem cell reawakening and normal brain growth. Loss of these proteins impaired neuronal development in experimental models, underscoring their biological importance.
Mechanistically, the team found that SUMOylation targets Warts (also known as Lats), the core kinase of the Hippo pathway. The Hippo pathway is a well-established regulator of cell proliferation, apoptosis and organ size, but its upstream regulators in the brain have been incompletely defined. SUMOylation of Warts reduces its phosphorylation by Hippo kinase, weakening Hippo pathway signaling. This attenuation releases the brake on neural stem cell growth, allowing reactivation and subsequent neuronal production.
Professor Wang Hongyan, Acting Programme Director of the Neuroscience and Behavioural Disorders Research Programme and the study’s senior author, emphasized conservation across species: SUMO proteins and Hippo pathway components are highly conserved in humans, so discoveries made in Drosophila are likely relevant to human biology. Disruption of SUMOylation or Hippo signaling has been implicated in cancers and neurodegenerative diseases; understanding these interactions in neural stem cells opens potential therapeutic strategies that harness intrinsic regenerative mechanisms.
The research team previously established fruit fly neural stem cells as a powerful model for studying dormancy, reactivation and neuronal regeneration. This study builds on that foundation to map a SUMO-Hippo regulatory axis that controls stem cell behavior during development and repair.
Professor Patrick Tan, Senior Vice-Dean for Research at Duke-NUS, noted that these insights expand fundamental knowledge of cellular regulation and support the development of new regenerative therapies for neurodegenerative diseases and developmental disorders like microcephaly.
Duke-NUS continues to pursue fundamental neuroscience research with a focus on translating basic discoveries into treatments that improve patient care. This study contributes to that mission by revealing molecular targets and pathways that could be leveraged to restore or enhance neural regeneration.
About this genetics and neuroscience research news
Author: Brandon Raeburn
Source: Duke NUS Medical School
Contact: Brandon Raeburn – Duke NUS Medical School
Image credit: Neuroscience News
Original research (open access): “SUMOylation of Warts Kinase Promotes Neural Stem Cell Reactivation” by Gao Yang et al., Nature Communications. The paper details how SUMO pathway components affect neural stem cell quiescence and proliferation in Drosophila and identifies SUMOylation of Warts/Lats as a molecular switch that inhibits Hippo signaling to initiate reactivation.
Abstract (summary)
SUMOylation of Warts Kinase Promotes Neural Stem Cell Reactivation
A precise balance between neural stem cell quiescence and proliferation is essential for healthy brain development and adult neurogenesis. SUMO-dependent post-translational modifications produce rapid and reversible changes in protein function, yet their specific role in neural stem cell reactivation was previously unclear.
This study demonstrates that key SUMO pathway components regulate neural stem cell reactivation and brain development in Drosophila. Loss of SUMO (Smt3) or the SUMO-conjugating enzyme Ubc9 causes defects in stem cell reactivation and brain formation, whereas overexpression promotes premature reactivation. Smt3 levels rise during reactivation, a process enhanced by Akt signaling. Warts/Lats kinase undergoes SUMOylation at Lys766 in a SUMO- and Ubc9-dependent manner; this modification reduces Warts phosphorylation by Hippo, thereby inhibiting the Hippo pathway and initiating neural stem cell reactivation. Inhibiting Hippo signaling also rescues reactivation defects caused by SUMO pathway disruption. Overall, the work uncovers a conserved SUMO–Hippo regulatory axis that controls neural stem cell behavior and brain development.